2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib. Cancer Discov. 2014;4(5):546-53.
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas. J Pathol. 2014;234(2):190-202.
Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics. Eur J Dermatol. 2014;24(5):594-602.
AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer. Cancer Res. 2014;74(24):7198-204.
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment. Cancer Epidemiol Biomarkers Prev. 2014;23(4):594-600.
SPOP mutations in prostate cancer across demographically diverse patient cohorts. Neoplasia. 2014;16(1):14-20.
A rare case of fetal adenocarcinoma of the lung. Ann Thorac Surg. 2014;98(6):2217-8.
Myelodysplastic syndromes in the United States: an update for clinicians. Ann Med. 2014;46(5):283-9.